FREE ON-DEMAND WEBINAR
In this third segment of our FDA: Case for Quality series, the FDA will discuss their focus on quality metrics and indicators versus compliance metrics and indicators, throughout the pilot program.
They will cover the reasoning behind this shift towards quality, the value it has for improving product quality, and how it fits into the future vision of the voluntary pilot program.
Furthermore, they will provide additional details of metrics that are now being shared by participants and how the agency intends to use them.
Finally, in this free 60 minute webinar presented by FDA Case for Quality Program Manager, Cisco Vicenty will provide an overview of what the next steps are for the pilot as we finish 2018 and move into 2019.